nach oben

Current Reviews in Musculoskeletal Medicine

Erschienen in:

09.05.2020 | Injuries in Overhead Athletes (J Dines and C Camp, Section Editors)

The Role of Biologic Agents in the Non-operative Management of Elbow Ulnar Collateral Ligament Injuries

verfasst von: John M. Apostolakos, Kenneth M. Lin, James B. Carr II, Asheesh Bedi, Christopher L. Camp, Joshua S. Dines

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Injuries to the elbow ulnar collateral ligament (UCL) are especially common in the overhead throwing athlete. Despite preventative measures, these injuries are occurring at increasing rates in athletes of all levels. UCL reconstruction techniques generally require a prolonged recovery period and introduce the potential for intraoperative complications prompting investigations into more conservative treatment measures based on specific patient and injury characteristics. The purpose of this review is to describe the current literature regarding the use of biologic augmentation in the management of UCL injuries. Specifically, this review will focus on the basic science background and clinical investigations pertaining to biologic augmentation utilizing platelet-rich plasma (PRP) and autologous stem cells.

Recent Findings

Despite some evidence supporting the use of PRP therapy in patients with partial UCL tears, there is no current consensus regarding its true efficacy. Similarly, due to a lack of clinical investigations, no consensus exists regarding the utilization of autologous stem cell treatments in the management of UCL injuries.

Summary

Management of UCL injuries ranges from non-operative treatment with focused physical therapy protocols to operative reconstruction. The use of biologic augmentation in these injuries continues to be investigated in the orthopedic community. Currently, no consensus exists regarding the efficacy of either PRP or autologous stem cells and further research is needed to further define the appropriate role of these treatments in the management of UCL injuries.

• Clark NJ, Desai VS, Dines JD, Morrey ME, Camp CL. Nonreconstruction options for treating medial ulnar collateral ligament injuries of the elbow in overhead athletes. Curr Rev Musculoskelet Med, Previous edition of a current concepts review on nonreconstruction management of UCL injuries in overhead athletes. 2018;11(1):48–54.

Cain EL Jr, Dugas JR, Wolf RS, Andrews JR. Elbow injuries in throwing athletes: a current concepts review. Am J Sports Med. 2003;31(4):621–35.PubMed

Freehill MT, Safran MR. Diagnosis and management of ulnar collateral ligament injuries in throwers. Curr Sports Med Rep. 2011;10(5):271–8.PubMed

Hodgins JL, Vitale M, Arons RR, Ahmad CS. Epidemiology of medial ulnar collateral ligament reconstruction: a 10-year study in New York state. Am J Sports Med. 2016;44(3):729–34.PubMed

• Li NY, Goodman AD, Lemme NJ, Owens BD. Epidemiology of elbow ulnar collateral ligament injuries in throwing versus contact athletes of the National Collegiate Athletic Association: analysis of the 2009–2010 to 2013–2014 seasons. Orthop J Sports Med. 2019;7(4):2325967119836428 An epidemiologic investigation of UCL injuries queried from the Naional Collegiate Athletic Association (NCAA) between the season of 2009–2010 and 2013–2014 in 25 varsity sports.PubMedPubMedCentral

Conte SA, Fleisig GS, Dines JS, Wilk KE, Aune KT, Patterson-Flynn N, et al. Prevalence of ulnar collateral ligament surgery in professional baseball players. Am J Sports Med. 2015;43(7):1764–9.PubMed

Conte S, Camp CL, Dines JS. Injury trends in Major League Baseball over 18 seasons: 1998-2015. Am J Orthop (Belle Mead NJ). 2016;45(3):116–23.

Erickson BJ, Nwachukwu BU, Rosas S, Schairer WW, McCormick FM, Bach BR Jr, et al. Trends in medial ulnar collateral ligament reconstruction in the United States: a retrospective review of a large private-payer database from 2007 to 2011. Am J Sports Med. 2015;43(7):1770–4.PubMed

Cain EL Jr, Andrews JR, Dugas JR, et al. Outcome of ulnar collateral ligament reconstruction of the elbow in 1281 athletes: results in 743 athletes with minimum 2-year follow-up. Am J Sports Med. 2010;38(12):2426–34.PubMed

10.

Dines JS, ElAttrache NS, Conway JE, Smith W, Ahmad CS. Clinical outcomes of the DANE TJ technique to treat ulnar collateral ligament insufficiency of the elbow. Am J Sports Med. 2007;35(12):2039–44.PubMed

11.

Erickson BJ, Bach BR Jr, Cohen MS, et al. Ulnar collateral ligament reconstruction: the rush experience. Orthop J Sports Med. 2016;4(1):2325967115626876.PubMedPubMedCentral

12.

Watson JN, McQueen P, Hutchinson MR. A systematic review of ulnar collateral ligament reconstruction techniques. Am J Sports Med. 2014;42(10):2510–6.PubMed

13.

• Rebolledo BJ, Dugas JR, Bedi A, Ciccotti MG, Altchek DW, Dines JS. Avoiding Tommy John Surgery: what are the alternatives? Am J Sports Med. 2017;45(13):3143–8 Clinical sports update on the clinical approach to patients with UCL injury focused on rehabilitation, biologic strategies, and operative options.PubMed

14.

•• Frangiamore SJ, Lynch TS, Vaughn MD, et al. Magnetic resonance imaging predictors of failure in the nonoperative management of ulnar collateral ligament injuries in professional baseball pitchers. Am J Sports Med. 2017;45(8):1783–9 A case-control study investigating the efficacy of objective measures to predict failure of the nonoperative managament of patients with UCL injuries. In professional pitchers, injuries to the distal UCL showed statistically higher odds of failure when managed nonoperatively as compared to proximal tears.PubMed

15.

•• Buckley PS, Morris ER, Robbins CM, et al. Variations in blood supply from proximal to distal in the ulnar collateral ligament of the elbow: a qualitative descriptive cadaveric study. Am J Sports Med. 2019;47(5):1117–23 A cadaveric investigation which reported the vascular supply of the proximal portion of the UCL to be well vasculatized while the distal portion was hypovascular. PubMed

16.

• Hurwit DJ, Garcia GH, Liu J, Altchek DW, Romeo A, Dines J. Management of ulnar collateral ligament injury in throwing athletes: a survey of the American Shoulder and Elbow Surgeons. J Shoulder Elbow Surg. 2017;26(11):2023–8 This study reported on results from an online survey distributed to members of the ASES regarding management of 7 distinct fictional clinical case scenerios of patients with UCL injury.PubMed

17.

Fralinger DJ, Kaplan DJ, Weinberg ME, Strauss EJ, Jazrawi LM. Biological treatments for tendon and ligament abnormalities: a critical analysis review. JBJS Rev. 2016;4(6).

18.

• Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med. 2018;11(4):583–92 Clinical update reporting on current research into the applications of PRP for knee osteo-arthritis.PubMedPubMedCentral

19.

• Barber FA. PRP as an adjunct to rotator cuff tendon repair. Sports Med Arthrosc Rev. 2018;26(2):42–7 Review on the efficacy of PRP as an adjunct to rotator cuff tendon repair. PubMed

20.

Hernigou P, Flouzat Lachaniette CH, Delambre J, Zilber S, Duffiet P, Chevallier N, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38(9):1811–8.PubMed

21.

Silva A, Sampaio R, Fernandes R, Pinto E. Is there a role for adult non-cultivated bone marrow stem cells in ACL reconstruction? Knee Surg Sports Traumatol Arthrosc. 2014;22(1):66–71.PubMed

22.

Connell D, Datir A, Alyas F, Curtis M. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med. 2009;43(4):293–8.PubMed

23.

Singh A, Gangwar DS, Singh S. Bone marrow injection: a novel treatment for tennis elbow. J Nat Sci Biol Med. 2014;5(2):389–91.PubMedPubMedCentral

24.

Pascual-Garrido C, Rolon A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012;2012:953510.PubMed

25.

Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–8.PubMed

26.

• Le ADK, Enweze L, DeBaun MR, Dragoo JL. Platelet-rich plasma. Clin Sports Med. 2019;38(1):17–44 Current concepts review on PRP treatment for various musculoskeletal injuries.

27.

Murray IR, LaPrade RF. Platelet-rich plasma: renewed scientific understanding must guide appropriate use. Bone Joint Res. 2016;5(3):92–4.PubMedPubMedCentral

28.

• Kia C, Baldino J, Bell R, Ramji A, Uyeki C, Mazzocca A. Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med. 2018;11(4):566–72 Current concepts review on PRP treatment for tendon and ligament pathology. PubMedPubMedCentral

29.

Ellera Gomes JL, da Silva RC, Silla LM, Abreu MR, Pellanda R. Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cells. Knee Surg Sports Traumatol Arthrosc. 2012;20(2):373–7.PubMed

30.

Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–72.

31.

Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–96.

32.

Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94(4):308–16.PubMed

33.

Podesta L, Crow SA, Volkmer D, Bert T, Yocum LA. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. Am J Sports Med. 2013;41(7):1689–94.PubMed

34.

Dines JS, Williams PN, ElAttrache N, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop (Belle Mead NJ). 2016;45(5):296–300.PubMed

35.

•• Deal JB, Smith E, Heard W, O'Brien MJ, Savoie FH 3rd. Platelet-rich plasma for primary treatment of partial ulnar collateral ligament tears: MRI correlation with results. Orthop J Sports Med. 2017;5(11):2325967117738238 A case-series reporting on patients with UCL injury who underwent primary treatment with PRP injection and guided rehabilitation. PubMedPubMedCentral

36.

•• Chauhan A, McQueen P, Chalmers PN, et al. Nonoperative treatment of elbow ulnar collateral ligament injuries with and without platelet-rich plasma in professional baseball players: a comparative and matched cohort analysis. Am J Sports Med. 2019;47(13):3107–19 A comparative cohort study reporting on outcomes following nonoperative treatment of elbow UCL injuries with and without PRP in professional baseball players. PubMed

37.

• Hevesi M, LaPrade M, Saris DBF, Krych AJ. Stem cell treatment for ligament repair and reconstruction. Curr Rev Musculoskelet Med. 2019;12(4):446–50 A current concepts review on stem cell treatment in the setting of ligament repair and reconstruction. PubMedPubMedCentral

38.

Ahmad Z, Wardale J, Brooks R, Henson F, Noorani A, Rushton N. Exploring the application of stem cells in tendon repair and regeneration. Arthroscopy. 2012;28(7):1018–29.PubMed

39.

Randelli P, Randelli F, Ragone V, et al. Regenerative medicine in rotator cuff injuries. Biomed Res Int. 2014;2014:129515.PubMedPubMedCentral

40.

Mazzocca AD, McCarthy MB, Chowaniec D, et al. Bone marrow-derived mesenchymal stem cells obtained during arthroscopic rotator cuff repair surgery show potential for tendon cell differentiation after treatment with insulin. Arthroscopy. 2011;27(11):1459–71.PubMed

41.

Perdisa F, Gostynska N, Roffi A, Filardo G, Marcacci M, Kon E. Adipose-derived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells Int. 2015;2015:597652.PubMedPubMedCentral

42.

Dragoo JL, Samimi B, Zhu M, et al. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br. 2003;85(5):740–7.PubMed

43.

Saw KY, Anz A, Siew-Yoke Jee C, Merican S, Ching-Soong Ng R, Roohi SA, et al. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4):684–94.PubMed

44.

• Carr JB 2nd, Rodeo SA. The role of biologic agents in the management of common shoulder pathologies: current state and future directions. J Shoulder Elbow Surg. 2019;28(11):2041–52 A review of the current state and future directions of biologic agents in the setting of shoulder pathology. PubMed

45.

Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.PubMed

46.

Clarke AW, Alyas F, Morris T, Robertson CJ, Bell J, Connell DA. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med. 2011;39(3):614–23.PubMed

47.

Lin K, Rodeo S. Tendon and ligament healing. In: Wolters Kluwer.

48.

Hernigou P, Homma Y, Flouzat Lachaniette CH, Poignard A, Allain J, Chevallier N, et al. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop. 2013;37(11):2279–87.PubMedPubMedCentral

49.

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.PubMed

50.

Hoffman JK, Protzman NM, Malhotra AD. Biologic augmentation of the ulnar collateral ligament in the elbow of a professional baseball pitcher. Case Rep Orthop. 2015;2015:130157.PubMedPubMedCentral

51.

Protzman NM, Stopyra GA, Hoffman JK. Biologically enhanced healing of the human rotator cuff: 8-month postoperative histological evaluation. Orthopedics. 2013;36(1):38–41.PubMed

52.

Gordon NM, Maxson S, Hoffman JK. Biologically enhanced healing of the rotator cuff. Orthopedics. 2012;35(6):498–504.PubMed

53.

Kanaya A, Deie M, Adachi N, Nishimori M, Yanada S, Ochi M. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007;23(6):610–7.PubMed

54.

Oe K, Kushida T, Okamoto N, Umeda M, Nakamura T, Ikehara S, et al. New strategies for anterior cruciate ligament partial rupture using bone marrow transplantation in rats. Stem Cells Dev. 2011;20(4):671–9.PubMed

55.

Ju YJ, Muneta T, Yoshimura H, Koga H, Sekiya I. Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Cell Tissue Res. 2008;332(3):469–78.PubMed

56.

Lim JK, Hui J, Li L, Thambyah A, Goh J, Lee EH. Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction. Arthroscopy. 2004;20(9):899–910.PubMed

57.

Petersen W, Tillmann B. Structure and vascularization of the cruciate ligaments of the human knee joint. Anat Embryol (Berl). 1999;200(3):325–34.

Titel: The Role of Biologic Agents in the Non-operative Management of Elbow Ulnar Collateral Ligament Injuries
verfasst von: John M. Apostolakos
Kenneth M. Lin
James B. Carr II
Asheesh Bedi
Christopher L. Camp
Joshua S. Dines
Publikationsdatum: 09.05.2020
Verlag: Springer US
Erschienen in: Current Reviews in Musculoskeletal Medicine / Ausgabe 4/2020
Elektronische ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-020-09637-9

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Role of Biologic Agents in the Non-operative Management of Elbow Ulnar Collateral Ligament Injuries

Abstract

Purpose of Review

Recent Findings

Summary

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Lateral Ligament Instability: Review of Pathology and Diagnosis

Using Patient Engagement Platforms in the Postoperative Management of Patients

Evaluation and Management of Preaxial Polydactyly

Hemiarthroplasty and Total Shoulder Arthroplasty Conversion to Reverse Total Shoulder Arthroplasty

Cannabinoid Use in Musculoskeletal Illness: a Review of the Current Evidence

Thoracic Outlet Syndrome in the Overhead Athlete: Diagnosis and Treatment Recommendations

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie